A Single-center, Open-label, Randomized, Two Way Crossover Study to Investigate the Food Effect on the Pharmacokinetics of ACT-541468 in Healthy Male Subjects
Latest Information Update: 15 Apr 2019
Price :
$35 *
At a glance
- Drugs Daridorexant (Primary)
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors Idorsia Pharmaceuticals
- 10 Apr 2019 Status changed from not yet recruiting to completed.
- 15 Jan 2019 New trial record